Peregrine Ventures, Israel's leading venture capital fund focusing on early stage investments with a strong emphasis on Life Sciences and Information Technology
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Mentions in press and media 16
| Date | Title | Description |
| 08.07.2025 | Restore Medical: $23 Million Series B Raised For Advancing Medical Device For Heart Failure Therapy | Restore Medical – a clinical-stage MedTech company developing transcatheter therapies for heart failure – announced the closing of a $23 million Series B financing round. The funding round is co-led by Pitango HealthTech and a global strate... |
| 25.07.2024 | The Rise of Farm Robotics: A New Era in Agriculture** ** | ** The agricultural landscape is changing. Like a field awakening at dawn, the farm robotics sector is blossoming, even amid economic challenges. In 2024, the sector has raised nearly $399 million, a drop from the previous year but still a ... |
| 25.07.2024 | The Rise of Farm Robotics: Navigating Challenges and Opportunities in 2024** ** | ** The agricultural landscape is undergoing a seismic shift. Farm robotics is at the forefront of this transformation. In 2024, the sector is grappling with funding challenges but is also witnessing a surge in innovation. As labor costs ris... |
| 25.07.2024 | The Rise of Farm Robotics: Navigating a New Era in Agriculture** ** | ** The agricultural landscape is changing. Like a field being tilled for the first time, the farm robotics sector is breaking new ground. In 2024, despite a challenging fundraising environment, this sector is showing resilience and innovati... |
| 24.07.2024 | The 7 biggest farm robotics deals of 2024 so far | The farm robotics sector has shown some resilience in 2024 and continues to bring innovative products to market, despite the challenging year for fundraising. In the first half of 2024, the AgFunder-defined Farm Robotics, Mechanization, and... |
| 30.11.2022 | Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies | What You Should Know: The company also announced dosing of the first patient in its Phase 1 clinical trial of NTX1088, Nectin’s first-in-class PVR blocker, in cancer patients with locally advanced and metastatic solid tumors. NTX1088 is a f... |
| 29.09.2021 | This Week in Agrifoodtech: Gorillas raises $950m, New Age Meats nets $25m & more | The past seven days saw major funding hauls for German food delivery startup Gorillas, US cultivated meat maker New Age Meats, and Canadian precision ag platform Semios. Elsewhere, AFN examined data that suggests that agriculture is far fro... |
| 23.09.2021 | Brief: Autonomous farming startup Blue White Robotics raises $37m Series B funding | Tel Aviv, Israel-based autonomous farming startup Blue White Robotics has raised $37 million in Series B funding, according to a press release sent to AFN. NYC-based VC firm Insight Partners co-led the round with Entrée Capital. Other parti... |
| 19.08.2021 | Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal | OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ: MTAC), a pu... |
| 19.08.2021 | Peregrine Ventures : Portfolio Company Memic Announces $1B Valuation SPAC deal | OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ: MTAC), a pu... |
Show more